|
| 南京医药(600713)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2026-01-26 | 506.50 | 0.39% | 129285.93 | 1646.68 | 128689.16 | 98.29% | 股权激励限售股份 | | 2025-11-21 | 49.30 | 0.04% | 128779.43 | 2153.18 | 128689.16 | 98.29% | 股权激励限售股份 | | 2025-02-21 | 25075.38 | 19.15% | 130291.06 | 641.54 | 104730.72 | 79.99% | 定向增发机构配售股份 | | 2025-02-17 | 484.96 | 0.37% | 105215.69 | 25716.92 | 104730.72 | 79.99% | 股权激励限售股份 | | 2024-11-26 | 44.78 | 0.03% | 104730.72 | 26201.88 | 104685.94 | 79.95% | 股权激励限售股份 | | 2024-02-02 | 524.82 | 0.40% | 104685.94 | 26337.16 | 104161.12 | 79.50% | 股权激励限售股份 | | 2021-02-05 | 14418.56 | 13.84% | 104161.12 | 0.00 | 104161.12 | 100.00% | 增发A股原股东配售上市 | | 2017-12-04 | 20384.49 | 22.71% | 89742.56 | 0.00 | 89742.56 | 100.00% | 增发A股原股东配售上市 | | 2013-05-22 | 14565.74 | 21.00% | 69358.07 | 0.00 | 69358.07 | 100.00% | 增发A股原股东配售上市 | | 2011-04-20 | 3623.73 | 10.45% | 27396.17 | 7282.87 | 34679.03 | 100.00% | 增发A股法人配售上市 | | 2007-07-17 | 5850.00 | 23.33% | 19810.36 | 5266.33 | 25076.69 | 100.00% | 股权分置限售流通 |
|